Sciencepharma Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Sciencepharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Real Estate | Real Estate Property Managers | Passenger Car Rental and Leasing | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Other Personal and Household Goods Repair and Maintenance

Full name: Sciencepharma Sp. z o.o.

Profile Updated: June 10, 2024

Sciencepharma Sp. z o.o. is based in Poland. The head office is in Warsaw. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on March 02, 2022. In its most recent financial highlights, the company reported a net sales revenue drop of 4.59% in 2023. Its total assets grew by 22.4% over the same period. Sciencepharma Sp. z o.o.’s net profit margin increased by 0.96% in 2023.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Sciencepharma Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Sciencepharma Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Sciencepharma Sp. z o.o. report to view the information.

Incorporation Date:

March 02, 2022

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Sciencepharma Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-4.59%▼

Total operating revenue

-5.12%▼

Operating profit (EBIT)

-73.09%▼

EBITDA

-72.01%▼

Net Profit (Loss) for the Period

16.35%▲

Total assets

22.4%▲

Total equity

119.6%▲

Operating Profit Margin (ROS)

-1.24%▼

Net Profit Margin

0.96%▲

Return on Equity (ROE)

-35.64%▼

Debt to Equity Ratio

-7.72%▼

Quick Ratio

0.29%▲

Cash Ratio

0.06%▲

Similar companies